Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transcriptional coactivator Eya1 exerts transcriptional repressive activity by interacting with REST corepressors and REST-binding sequences to maintain nephron progenitor identity. | Nucleic Acids Res | 2022 | 36130284 | PubTator, text mining | PubMed |
| Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model. | Oncotarget | 2022 | 36128326 | PubTator, text mining | PubMed |
| Diverse ancestry whole-genome sequencing association study identifies TBX5 and PTK7 as susceptibility genes for posterior urethral valves. | Elife | 2022 | 36124557 | PubTator, text mining | PubMed |
| Optimization of differentiation protocols of dental tissues stem cells to pancreatic β-cells. | BMC Mol Cell Biol | 2022 | 36123594 | PubTator, text mining | PubMed |
| CTCF acetylation at lysine 20 is required for the early cardiac mesoderm differentiation of embryonic stem cells. | Cell Regen | 2022 | 36117192 | PubTator, text mining | PubMed |
| 7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome. | Elife | 2022 | 36111785 | PubTator, text mining | PubMed |
| Induction of functional xeno-free MSCs from human iPSCs via a neural crest cell lineage. | NPJ Regen Med | 2022 | 36109564 | PubTator, text mining | PubMed |
| Mimicry of embryonic circulation enhances the hoxa hemogenic niche and human blood development. | Cell Rep | 2022 | 36103836 | PubTator, text mining | PubMed |
| Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis. | Biology (Basel) | 2022 | 36101460 | PubTator, text mining | PubMed |
| Mir-122 upregulation and let-7f downregulation combination: The effects on hepatic differentiation of hiPSCs on the PCL-Gel-HA nanofibrous scaffold. | J Cell Mol Med | 2022 | 36098216 | PubTator, text mining | PubMed |
| Strategies for Mammalian Mesenchymal Stem Cells Differentiation into Primordial Germ Cell-Like Cells: A Review. | Cell J | 2022 | 36093802 | PubTator, text mining | PubMed |
| The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients. | Front Mol Biosci | 2022 | 36090038 | PubTator, text mining | PubMed |
| Using CRISPR/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel CCM1 transcription start site deletion. | Front Mol Biosci | 2022 | 36090026 | PubTator, text mining | PubMed |
| Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy. | NPJ Regen Med | 2022 | 36085325 | PubTator, text mining | PubMed |
| Melanoma Tumour Vascularization and Tissue-Resident Endothelial Progenitor Cells. | Cancers (Basel) | 2022 | 36077754 | PubTator, text mining | PubMed |
| Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. | Int J Mol Sci | 2022 | 36076918 | PubTator, text mining | PubMed |
| Integrative network analysis of circular RNAs reveals regulatory mechanisms for hepatic specification of human iPSC-derived endoderm. | Stem Cell Res Ther | 2022 | 36076262 | PubTator, text mining | PubMed |
The Biomarker Like the Correlation between Vasculogenic Mimicry, Vascular Endothelial Cadherin, Sex-DeterminingRegion on Y-Box Transcription Factor 17, and Cyclin D1 in Oesophageal Squamous Cell Carcinoma. | J Oncol | 2022 | 36072972 | PubTator, text mining | PubMed |
| Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues. | Genome Biol | 2022 | 36071529 | PubTator, text mining | PubMed |
| PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest. | Nat Commun | 2022 | 36068222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=45